Level One Partners Supports Watermill’s Proposal for Ziopharm Oncology

Level One Partners, LLC, (Level One Partners) along with all of its related entities, will vote 100% of its approximately 10.68 million shares of Ziopharm Oncology, Inc. (NASDAQ: ZIOP) (Ziopharm or the Company) in support of the WaterMill Asset Management Corp. proposal for a reconstituted Board of Directors and significant changes to the governance of the Company.